These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25279290)

  • 41. Inspiratory flows and volumes in subjects with cystic fibrosis using a new dry powder inhaler device.
    Elkins MR; Robinson P; Anderson SD; Perry CP; Daviskas E; Charlton B
    Open Respir Med J; 2014; 8():1-7. PubMed ID: 24570763
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of inhalation flow patterns of soft mist inhaler co-prescribed with dry powder inhaler using inspiratory flow meter for multi inhalation devices.
    Hira D; Koide H; Nakamura S; Okada T; Ishizeki K; Yamaguchi M; Koshiyama S; Oguma T; Ito K; Funayama S; Komase Y; Morita SY; Nishiguchi K; Nakano Y; Terada T
    PLoS One; 2018; 13(2):e0193082. PubMed ID: 29462195
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estimation of inhalation flow profile using audio-based methods to assess inhaler medication adherence.
    Taylor TE; Lacalle Muls H; Costello RW; Reilly RB
    PLoS One; 2018; 13(1):e0191330. PubMed ID: 29346430
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sensitivity of Turbutester and Accuhaler tester in asthmatic children and adolescents.
    Manuyakorn W; Direkwattanachai C; Benjaponpitak S; Kamchaisatian W; Sasisakulporn C; Teawsomboonkit W
    Pediatr Int; 2010 Feb; 52(1):118-25. PubMed ID: 19508454
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
    Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
    Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association between peak inspiratory flow rate and hand grip muscle strength in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease.
    Samarghandi A; Ioachimescu OC; Qayyum R
    PLoS One; 2020; 15(1):e0227737. PubMed ID: 32004333
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prospective evAluatIon foR inhalation devices in Greek patients with COPD and asthma: The PAIR study.
    Karampitsakos T; Hillas G; Zervas E; Bakakos P; Stratakos G; Dimakou K; Manali E; Bouros D; Papiris S; Tzouvelekis A;
    Pulm Pharmacol Ther; 2020 Feb; 60():101882. PubMed ID: 31881275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Appropriate use of a dry powder inhaler based on inhalation flow pattern.
    Kondo T; Hibino M; Tanigaki T; Cassan SM; Tajiri S; Akazawa K
    J Pharm Health Care Sci; 2017; 3():5. PubMed ID: 28116116
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial.
    Altman P; Wehbe L; Dederichs J; Guerin T; Ament B; Moronta MC; Pino AV; Goyal P
    BMC Pulm Med; 2018 Jun; 18(1):100. PubMed ID: 29898702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dose delivery characteristics of the AIR pulmonary delivery system over a range of inspiratory flow rates.
    DeLong M; Wright J; Dawson M; Meyer T; Sommerer K; Dunbar C
    J Aerosol Med; 2005; 18(4):452-9. PubMed ID: 16379620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Confusing World of Dry Powder Inhalers: It Is All About Inspiratory Pressures, Not Inspiratory Flow Rates.
    Clark AR; Weers JG; Dhand R
    J Aerosol Med Pulm Drug Deliv; 2020 Feb; 33(1):1-11. PubMed ID: 31613682
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inspiratory Flows and Volumes in Subjects with Non-CF Bronchiectasis Using a New Dry Powder Inhaler Device.
    Elkins MR; Anderson SD; Perry CP; Daviskas E; Charlton B
    Open Respir Med J; 2014; 8():8-13. PubMed ID: 24570764
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Impact of Common Inhaler Errors on Drug Delivery: Investigating Critical Errors with a Dry Powder Inhaler.
    Sulaiman I; Seheult J; Sadasivuni N; MacHale E; Killane I; Giannoutsos S; Cushen B; Mokoka MC; Bhreathnach AS; Boland F; Reilly RB; Costello RW
    J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):247-255. PubMed ID: 28277810
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Wixela Inhub: Dosing Performance
    Cooper A; Parker J; Berry M; Wallace R; Ward J; Allan R
    J Aerosol Med Pulm Drug Deliv; 2020 Dec; 33(6):323-341. PubMed ID: 32429788
    [No Abstract]   [Full Text] [Related]  

  • 55. Deposition and fine particle production during dynamic flow in a dry powder inhaler: a CFD approach.
    Milenkovic J; Alexopoulos AH; Kiparissides C
    Int J Pharm; 2014 Jan; 461(1-2):129-36. PubMed ID: 24296048
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Selection of a personal dry powder inhaler based on peak inspiratory flow measurements in selected groups of patients with bronchial obstruction].
    Kokot M
    Pol Merkur Lekarski; 2000 Oct; 9(52):672-6. PubMed ID: 11144054
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of PIFR-based optimised inhalation therapy in patients recovering from acute exacerbation of chronic obstructive pulmonary disease: protocol of a prospective, multicentre, superiority, randomised controlled trial.
    Hua J; Zhang W; Cao HF; Du CL; Ma JY; Zuo YH; Zhang J
    BMJ Open; 2020 May; 10(5):e034804. PubMed ID: 32385061
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Validating Whole-Airway CFD Predictions of DPI Aerosol Deposition at Multiple Flow Rates.
    Longest PW; Tian G; Khajeh-Hosseini-Dalasm N; Hindle M
    J Aerosol Med Pulm Drug Deliv; 2016 Dec; 29(6):461-481. PubMed ID: 27082824
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical equivalence of budesonide dry powder inhaler and pressurized metered dose inhaler.
    Srichana T; Juthong S; Thawithong E; Supaiboonpipat S; Soorapan S
    Clin Respir J; 2016 Jan; 10(1):74-82. PubMed ID: 25043636
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inspiratory flow patterns with dry powder inhalers of low and medium flow resistance in patients with pulmonary arterial hypertension.
    Faria-Urbina M; Ung KT; Lawler L; Zisman LS; Waxman AB
    Pulm Circ; 2021; 11(2):20458940211012591. PubMed ID: 34035895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.